PYRIMETHAMINE LEUCOVORIN- pyrimethamine leucovorin capsule 
ImprimisRx PA, Inc. d/b/a ImprimisRx

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

Pyrimethamine Leucovorin (12.5mg-2.5mg)

Pyrimethamine Leucovorin (12.5mg-2.5mg)

image description

PYRIMETHAMINE LEUCOVORIN 
pyrimethamine leucovorin capsule
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:70271-430
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
PYRIMETHAMINE (UNII: Z3614QOX8W) (PYRIMETHAMINE - UNII:Z3614QOX8W) PYRIMETHAMINE12.5 mg
LEUCOVORIN CALCIUM (UNII: RPR1R4C0P4) (LEUCOVORIN - UNII:Q573I9DVLP) LEUCOVORIN2.5 mg
Inactive Ingredients
Ingredient NameStrength
CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U) 100 mg
Product Characteristics
Colorpink, blueScoreno score
ShapecapsuleSize15mm
FlavorImprint Code
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:70271-430-01100 in 1 BOTTLE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other11/27/2015
Labeler - ImprimisRx PA, Inc. d/b/a ImprimisRx (080044737)

Revised: 11/2015
Document Id: 02f3ee8d-9861-4519-8041-70d3687199e7
Set id: 6f79fc4a-41fc-4368-9312-8baebd985df0
Version: 1
Effective Time: 20151127
 
ImprimisRx PA, Inc. d/b/a ImprimisRx